GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » E10

Microbot Medical (FRA:CY9D) E10 : €-101.25 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Microbot Medical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Microbot Medical's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.180. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-101.25 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 35.80% per year. During the past 5 years, the average E10 Growth Rate was 34.30% per year. During the past 10 years, the average E10 Growth Rate was 26.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Microbot Medical was 35.80% per year. The lowest was 9.50% per year. And the median was 13.10% per year.

As of today (2025-03-17), Microbot Medical's current stock price is €1.306. Microbot Medical's E10 for the quarter that ended in Sep. 2024 was €-101.25. Microbot Medical's Shiller PE Ratio of today is .


Microbot Medical E10 Historical Data

The historical data trend for Microbot Medical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical E10 Chart

Microbot Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,081.53 -609.98 -481.54 -306.25 -206.27

Microbot Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -202.32 -206.27 -147.00 -118.51 -101.25

Competitive Comparison of Microbot Medical's E10

For the Medical Instruments & Supplies subindustry, Microbot Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Microbot Medical's Shiller PE Ratio falls into.



Microbot Medical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Microbot Medical's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.18/133.0289*133.0289
=-0.180

Current CPI (Sep. 2024) = 133.0289.

Microbot Medical Quarterly Data

per share eps CPI Adj_EPS
201412 -197.073 99.070 -264.626
201503 -201.998 99.621 -269.738
201506 -128.704 100.684 -170.051
201509 -128.704 100.392 -170.546
201512 -118.973 99.792 -158.598
201603 -0.135 100.470 -0.179
201606 -0.133 101.688 -0.174
201609 -3.609 101.861 -4.713
201612 -2.445 101.863 -3.193
201703 -0.561 102.862 -0.726
201706 -1.201 103.349 -1.546
201709 -0.378 104.136 -0.483
201712 -0.431 104.011 -0.551
201803 -0.405 105.290 -0.512
201806 -0.565 106.317 -0.707
201809 -0.514 106.507 -0.642
201812 -0.545 105.998 -0.684
201903 -0.425 107.251 -0.527
201906 -0.319 108.070 -0.393
201909 -0.400 108.329 -0.491
201912 -0.387 108.420 -0.475
202003 -0.281 108.902 -0.343
202006 -0.231 108.767 -0.283
202009 -0.297 109.815 -0.360
202012 -0.304 109.897 -0.368
202103 -0.286 111.754 -0.340
202106 -0.291 114.631 -0.338
202109 -0.306 115.734 -0.352
202112 -0.478 117.630 -0.541
202203 -0.409 121.301 -0.449
202206 -0.464 125.017 -0.494
202209 -0.495 125.227 -0.526
202212 -0.359 125.222 -0.381
202303 -0.336 127.348 -0.351
202306 -0.231 128.729 -0.239
202309 -0.197 129.860 -0.202
202312 -0.238 129.419 -0.245
202403 -0.156 131.776 -0.157
202406 -0.158 132.554 -0.159
202409 -0.180 133.029 -0.180

Add all the adjusted EPS together and divide 10 will get our e10.


Microbot Medical  (FRA:CY9D) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Microbot Medical E10 Related Terms

Thank you for viewing the detailed overview of Microbot Medical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbot Medical Business Description

Traded in Other Exchanges
Address
288 Grove Street, Suite 388, Braintree, MA, USA, 02184
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Microbot Medical Headlines

No Headlines